INTERNATIONAL PATENT: GMP BIOTECHNOLOGY LIMITED, TRIEU, VUONG FILES APPLICATION FOR "THERAPEUTICS FOR CANCER USING TGFB2 AND TGM6"

GENEVA, Nov. 19 -- GMP BIOTECHNOLOGY LIMITED (Unit 2212, 22/F, CC Wu Building302-308 Hennessy Road WanchaiHong Kong, Hong Kong), TRIEU, Vuong (29397 Agoura Road, Suite 107Agoura Hills, California 91301) filed a patent application (PCT/US2025/028505) for "THERAPEUTICS FOR CANCER USING TGFB2 AND TGM6" on May 08, 2025. With publication no. WO/2025/235822, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GMP BIOTECHNOLOGY LIMITED (Unit 2212, 22/F, CC Wu Building302-308 Hennessy Road WanchaiHong Kong, Hong Kong), TRIEU, Vuong (...